Cheng, Xinyu
Zong, Zhiyi
Mei, Xiaofei
Jiang, Yufeng
Shen, Jinsheng
Jiang, Hezi
Xu, Hui
Zhou, Yafeng
Funding for this research was provided by:
Research on Collaborative Innovation of medical engineering combination (SZM2022003, SZM2021014, SZM2022003)
grants from National Natural Science Foundation of China (81873486)
the Science and Technology Development Program of Jiangsu Province-Clinical Frontier Technology (BE2022754)
Clinical Medicine Expert Team (Class A) of Jinji Lake Health Talents Program of Suzhou Industrial Park (SZYQTD202102)
Suzhou Key Discipline for Medicine (SZXK202129)
Demonstration of Scientific and Technological Innovation Project (SKY2021002)
Suzhou Dedicated Project on Diagnosis and Treatment Technology of Major Diseases (LCZX202132)
Suzhou Key Laboratory of Diagnosis and Treatment of Panvascular Diseases (SZS2023021)
Article History
Received: 24 November 2024
Accepted: 14 January 2025
First Online: 12 February 2025
Declarations
:
: This study was approved by the Ethics Committee of The Fourth Affiliated Hospital of Soochow University( Suzhou Dushu Lake Hospital) (approval No.210047) and the methods were carried out in accordance with the approved guidelines. All the patients have been informed and signed informed consent before the experiments. This research does not cause harm to participants and does not involve sensitive personal information. This study complies with the principles expressed in the Declaration of Helsinki. Moreover, this study complies with the ethical exemption requirements of the “Ethical Review Measures for Life Sciences and Medical Research Involving Humans” promulgated by China.
: Not applicable.
: The authors declare no competing interests.